View in EDS

Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.

Saved in:
Bibliographic Details
Title: Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.
Authors: Blais JE; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China., Yan VK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China., Zhao J; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Digital and Data Innovation, AstraZeneca Global R&D (China) Co, Ltd, 200000 Shanghai, China., Chui CS; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Nursing, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China., Wong IC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Aston Pharmacy School, Aston University, B4 7ET Birmingham, UK., Siu CW; Division of Cardiology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, 518000 Shenzhen, GuangDong, China.; The University of Hong Kong Shenzhen Institute of Research and Innovation, 518000 Shenzhen, GuangDong, China.
Source: Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2022 Sep 26; Vol. 23 (10), pp. 327. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: IMR Press Country of Publication: Singapore NLM ID: 100960007 Publication Model: eCollection Cited Medium: Internet ISSN: 2153-8174 (Electronic) Linking ISSN: 15306550 NLM ISO Abbreviation: Rev Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2153-8174
DOI:10.31083/j.rcm2310327